Hangzhou Sciwind Biosciences
Pre-Approval PRO BETAPipeline by Phase
Therapeutic Focus
Clinical Trials (11)
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea But Not Receive Positive Airway Pressure Therapy
Started: 2/9/2026
A Study of XW003 in Obese Participants With Obstructive Sleep Apnea Receiving Positive Airway Pressure Therapy
Started: 3/2/2026
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Placebo in T2DM Patients
Started: 12/29/2022
A Phase 3 Study to Evaluate the Efficacy of XW003 Compared With Dulaglutide in Participants With T2DM
Started: 1/10/2023
A Phase 3 Study to Evaluate the Efficacy of XW003 in Adults With Overweight or Obesity
Started: 4/5/2023
A Study to Compare XW003 Injection and Semaglutide Injection in Chinese Adults With Obesity (SLIMMER-UP-SWITCH)
Started: 7/28/2025
A Phase Ib/IIa Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Oral Ecnoglutide Tablets in Chinese Participants With Overweight or Obesity
Started: 11/18/2025
A Study of XW003 Injection in Chinese Adolescents With Obesity
Started: 8/25/2025
A Study To Evaluate the Safety of XW001 Inhalation in Children With RSV
Started: 4/20/2023
A Drug-Drug Interaction Study Between XW003 and Metformin, Warfarin, Rosuvastatin or Digoxin
Started: 7/14/2023